Dr. Nir Qvit develops peptide therapeutics and diagnostic probes for mitochondrial, kinase, and immune pathways. He holds patents on mitochondrial fission and PDK regulation and has led multi‑million programs across Europe and the U.S., including PeptLab/Paris‑Seine and University of Florence.